ChiCTR2500115829 版本V1.0 版本创建时间2025/12/31 15:29:47 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2500115829 

最近更新日期:

Date of Last Refreshed on:

2025-12-31 15:29:25 

注册时间:

Date of Registration:

2025-12-31 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

青少年抑郁障碍伴不良饮食行为患者微生物-肠-脑轴功能改变及相关性研究

Public title:

A Probiotic Intervention for Adolescents Functional Alterations of the Microbiota-Gut-Brain Axis and Their Correlations in Adolescent Depressive Disorder Patients with Disordered Eating Behaviorswith Depression and Disordered Eating Behaviors

注册题目简写:

益生菌对伴有不良饮食行为的青少年抑郁患者的干预研究

English Acronym:

A Probiotic Intervention for Adolescents with Depression and Disordered Eating Behaviors

研究课题的正式科学名称:

青少年抑郁障碍伴不良饮食行为患者微生物-肠-脑轴功能改变及相关性研究

Scientific title:

Functional Alterations of the Microbiota-Gut-Brain Axis and Their Correlations in Adolescent Depressive Disorder Patients with Disordered Eating Behaviors

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

张月 

研究负责人:

张月 

Applicant:

Yue Zhang 

Study leader:

zhang yue 

申请注册联系人电话:

Applicant telephone:

+86 188 6641 8505

研究负责人电话:

Study leader's telephone:

+86 531 8633 6435

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

zhangyue_luna@163.com

研究负责人电子邮件:

Study leader's E-mail:

zhangyue_luna@163.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

山东省济南市历下区文化东路49号

研究负责人通讯地址:

文化东路49号-山东省精神卫生中心燕山院区科教部

Applicant address:

No.49 Wenhua East Road, Lixia District, Jinan City, Shandong Province

Study leader's address:

49 Wenhua East Road - room 710, science and education department, outpatient building, Shandong mental health center

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

山东省精神卫生中心

Applicant's institution:

Shandong Provincial Mental Health Center

研究负责人所在单位:

山东省精神卫生中心

Affiliation of the Leader:

Shandong mental health center

是否获伦理委员会批准:

是/Yes

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

KYSJWLL2025-1-095

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

山东省精神卫生中心伦理委员会

Name of the ethic committee:

Ethics Committee of Shandong Mental Health Center

伦理委员会批准日期:

Date of approved by ethic committee:

2025-12-10 00:00:00

伦理委员会联系人:

戴媛媛

Contact Name of the ethic committee:

Dai YuanYuan

伦理委员会联系地址:

文化东路49号-山东省精神卫生中心燕山院区科教部

Contact Address of the ethic committee:

49 Wenhua East Road - room 710, science and education department, outpatient building, Shandong mental health center

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 531 8633 6621

伦理委员会联系人邮箱:

Contact email of the ethic committee:

412882716@qq.com

研究实施负责(组长)单位:

山东省精神卫生中心

Primary sponsor:

Shandong mental health center

研究实施负责(组长)单位地址:

文化东路49号-山东省精神卫生中心燕山院区科教部

Primary sponsor's address:

49 Wenhua East Road - room 710, science and education department, outpatient building, Shandong mental health center

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

山东省

市(区县):

Country:

China

Province:

Shandong

City:

单位(医院):

山东省精神卫生中心

具体地址:

文化东路49号-山东省精神卫生中心燕山院区科教部

Institution
hospital:

Shandong mental health center

Address:

49 Wenhua East Road - room 710, science and education department, outpatient building, Shandong mental health center

经费或物资来源:

山东省医药卫生科技发展计划(青年项目)

Source(s) of funding:

Shandong Provincial Medical and Health Science and Technology Development Plan (Youth Project)

Target disease:

Adolescent Depressive Disorder with Disordered Eating Behaviors

Target disease code:

研究类型:

干预性研究

Study type:

Interventional study

研究所处阶段:

其它 

Study phase:

N/A

研究设计:

随机平行对照 

Study design:

Parallel 

研究目的:

1.探究特征:探究伴有不良饮食行为的青少年抑郁障碍患者其肠道菌群的组成、多样性及功能特征。2.阐明机制:阐明肠道菌群如何通过微生物-肠-脑轴(通过炎症因子、代谢产物等中介)影响抑郁症状与饮食行为。3.评估干预:初步评估为期4周的益生菌干预对改善该人群抑郁症状及不良饮食行为的效果与可行性。  

Objectives of Study:

1.Investigate Characteristics: To investigate the composition, diversity, and functional characteristics of gut microbiota in adolescent depressive disorder patients with disordered eating behaviors.2.Elucidate Mechanisms: To elucidate how gut microbiota influences depressive symptoms and eating behaviors via the microbiota-gut-brain axis (through mediators such as inflammatory factors and metabolites).3.Evaluate Intervention: To preliminarily evaluate the effect and feasibility of a 4-week probiotic intervention on improving depressive symptoms and disordered eating behaviors in this population.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

1.年龄12~18周岁;
2.疾病诊断符合《疾病和有关健康问题的国际统计分类》 第 10 版(ICD-10)中抑郁障碍的标准;
3.疾病诊断不符合ICD- 10中任何进?障碍(如神经性贪?、 暴?障碍等)的标准;
4.?组前未进?治疗或未采取电休克等其他?预措施;
5.能够理解并配合整个研究过程;

Inclusion criteria

1.Aged 12-18 years;
2.Meets ICD-10 diagnostic criteria for depressive disorder.
3.No history of treatment or interventions (e.g., electroconvulsive therapy) before enrollment.
4.Capacity to comprehend and cooperate with the entire study procedure.

排除标准:

1.患有其他主要精神障碍(如精神分裂症、双相情感障碍)或进食障碍。
2.患有严重或不稳定的躯体疾病。
3.近1个月服用过影响免疫或食欲的药物。
4.无法配合完成评估。

Exclusion criteria:

1.Diagnosed with other major psychiatric disorders (e.g., schizophrenia, bipolar disorder) or eating disorders.
2.Has severe or unstable physical illnesses.
3.Has taken medications affecting immunity or appetite within the past month.
4.Unable to cooperate with the assessments.

研究实施时间:

Study execute time:

From 2026-01-01 00:00:00 To 2027-12-31 00:00:00  

征募观察对象时间:

Recruiting time:

From 2026-01-01 00:00:00 To 2026-06-30 00:00:00  

干预措施:

Interventions:

组别:

不伴有异常进食行为-安慰剂组

样本量:

25

Group:

No Abnormal Eating Behavior - Placebo Group

Sample size:

干预措施:

安慰剂

干预措施代码:

Intervention:

placebo

Intervention code:

组别:

伴有异常进食行为-安慰剂组

样本量:

25

Group:

Abnormal Eating Behavior - Placebo Group

Sample size:

干预措施:

安慰剂

干预措施代码:

Intervention:

placebo

Intervention code:

组别:

不伴有异常进食行为 + 益生菌干预

样本量:

25

Group:

No Abnormal Eating Behavior - Probiotic Group

Sample size:

干预措施:

益生菌干预

干预措施代码:

Intervention:

Probiotic Intervention

Intervention code:

组别:

伴有异常进食行为组 + 益生菌干预

样本量:

25

Group:

Abnormal Eating Behavior - Probiotic Group

Sample size:

干预措施:

益生菌干预

干预措施代码:

Intervention:

Probiotic Intervention

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

山东省 

市(区县):

 

Country:

China 

Province:

Shandong 

City:

 

单位(医院):

山东省精神卫生中心 

单位级别:

三级甲等 

Institution
hospital:

Shandong mental health center

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

肠道菌群组成与多样性

指标类型:

主要指标

Outcome:

Gut Microbiota Composition and Diversity (16SrDNA Sequencing)

Type:

Primary indicator

测量时间点:

基线(干预前)、干预4周后

测量方法:

16SrDNA测序分析

Measure time point of outcome:

Baseline, Post-intervention (Week 4)

Measure method:

16SrDNA

指标中文名:

食物成瘾倾向评分(YFAS)

指标类型:

主要指标

Outcome:

Yale Food Addiction Scale (YFAS) Score

Type:

Primary indicator

测量时间点:

基线(干预前)、干预4周后

测量方法:

耶鲁食物成瘾量表(YFAS)

Measure time point of outcome:

Baseline, Post-intervention (Week 4)

Measure method:

YFAS questionnaire (symptom count method)

指标中文名:

荷兰饮??为问卷

指标类型:

次要指标

Outcome:

Dutch Eating Behaviours Questionnaire, DEBQ

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

17项汉密尔顿抑郁量表

指标类型:

次要指标

Outcome:

17-item Hamilton Depression Scale,HAMD

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

汉密尔顿焦虑量表

指标类型:

次要指标

Outcome:

Hamilton Anxiety Rating Scale,HAMA

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

血液

组织:

Sample Name:

Fasting venous blood

Tissue:

人体标本去向

使用后保存  

说明

Fate of sample:

Preservation after use  

Note:

标本中文名:

粪便

组织:

Sample Name:

Fresh fecal sample

Tissue:

人体标本去向

使用后保存  

说明

Fate of sample:

Preservation after use  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age 12 years
最大 Max age 18 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

由统计专家使用SPSS 23.0生成区组随机序列

Randomization Procedure (please state who generates the random number sequence and by what method):

Block randomization (block size=4) using SPSS 23.0

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

不公开/Private

盲法:

双盲

Blinding:

Double blind

是否共享原始数据:

IPD sharing

Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

研究完成且主要结果发表后,经脱敏处理的匿名个体参与者数据(IPD)可在合理要求下共享。数据将通过受控访问平台提供,具体公开日期预计不早于末次随访结束后24个月。

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

Anonymized IPD will be made available upon reasonable request to qualified researchers after the publication of primary findings, via a controlled-access repository. The expected availability date is no earlier than 24 months after study completion.

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

数据采集将使用标准化的病例报告表(CRF),包括自制人口学问卷、耶鲁食物成瘾量表(YFAS)、荷兰饮食行为问卷(DEBQ)、汉密尔顿抑郁/焦虑量表(HAMD/HAMA)等。所有数据将由双人独立录入,使用SPSS 23.0软件建立数据库并进行逻辑核查与管理。

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Data will be collected using standardized Case Report Forms (CRFs). All data will be independently double-entered and managed using SPSS 23.0 software with logic checks.

数据与安全监察委员会:

Data and Safety Monitoring Committee:

无/No

注册人:

Name of Registration:

 2025-12-31 15:29:25